The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
Open accessAbstract
The possibility of HIV-1 eradication has been limited by the existence of latently infected cellular reservoirs. Studies to examine control of HIV latency and potential reactivation have been hindered by the small numbers of latently infected cells found in vivo. Major conceptual leaps have been facilitated by the use of latently infected T cell lines and primary cells. However, notable differences exist among cell model systems. Furthermore, screening efforts in specific cell models have identified drug candidates for "anti-latency" therapy, which often fail to reactivate HIV uniformly across different models. Therefore, the activity of a given drug candidate, demonstrated in a particular cellular model, cannot reliably predict its activity in other cell model systems or in infected patient cells, tested ex vivo. This situation represents a critical knowledge gap that adversely affects our ability to identify promising treatment compounds and hinders the advancement of drug testing into relevant animal models and clinical trials. To begin to understand the biological characteristics that are inherent to each HIV-1 latency model, we compared the response properties of five primary T cell models, four J-Lat cell models and those obtained with a viral outgrowth assay using patient-derived infected cells. A panel of thirteen stimuli that are known to reactivate HIV by defined mechanisms of action was selected and tested in parallel in all models. Our results indicate that no single in vitro cell model alone is able to capture accurately the ex vivo response characteristics of latently infected T cells from patients. Most cell models demonstrated that sensitivity to HIV reactivation was skewed toward or against specific drug classes. Protein kinase C agonists and PHA reactivated latent HIV uniformly across models, although drugs in most other classes did not.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Self-citationOpen source clustering software
de Hoon, M. J. L., Imoto, S., Nolan, J., & Miyano, S. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth078 · Cited by 3,043
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991
Pvclust: an R package for assessing the uncertainty in hierarchical clustering
Suzuki, R., & Shimodaira, H. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl117 · Cited by 2,451
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Self-citationQuantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050
Self-citationHIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815 · cited 1×
“Acetylated histones have long been associated with actively transcribed genes [59] and, therefore, inhibitors of HDAC (HDACi) are considered as general activators of transcription.”
BackgroundOsborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
Archin, N. M., Liberty, A. L., Kashuba, A. D., Choudhary, S. K., Kuruc, J. D., Crooks, A. M., Parker, D. C., Anderson, E. M., Kearney, M. F., Strain, M. C., et al. (2012) · Nature · doi:10.1038/nature11286 · Cited by 1,139
Self-citationHIV reproducibly establishes a latent infection after acute infection of T cells in vitro
Jordan, A., Bisgrove, D., & Verdin, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg188 · Cited by 914
Self-citationDuh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., & Rabson, A. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5974 · Cited by 767
Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H., & Fauci, A. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2365 · Cited by 712
Deeks, S. G. (2012) · Nature · doi:10.1038/487439a · Cited by 604
Protein kinase C, an elusive therapeutic target?
Mochly-Rosen, D., Das, K., & Grimes, K. V. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3871 · Cited by 563
Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells
Seddon, B., Tomlinson, P., & Zamoyska, R. (2003) · Nature Immunology · doi:10.1038/ni946 · Cited by 456
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., & Verdin, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000495 · Cited by 374
Self-citationPomerantz, R. J., Trono, D., Feinberg, M. B., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90691-7 · Cited by 365
OPERating ON Chromatin, a Colorful Language where Context Matters
Gardner, K. E., Allis, C. D., & Strahl, B. D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.040 · Cited by 361
Messi, M., Giacchetto, I., Nagata, K., Lanzavecchia, A., Natoli, G., & Sallusto, F. (2003) · Nature Immunology · doi:10.1038/ni872 · Cited by 346
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Bosque, A., & Planelles, V. (2009) · Blood · doi:10.1182/blood-2008-07-168393 · Cited by 340
Self-citationExpression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., & Margolis, D. M. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0191 · Cited by 336
Self-citationKulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R., & Pomerantz, R. J. (2001) · Blood · doi:10.1182/blood.v98.10.3006 · Cited by 329
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Contreras, X., Schweneker, M., Chen, C.-S., McCune, J. M., Deeks, S. G., Martin, J., & Peterlin, B. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807898200 · Cited by 277
Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription
Lewinski, M. K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6610-6619.2005 · Cited by 270
Self-citationYang, H.-C., Xing, S., Shan, L., O’Connell, K., Dinoso, J., Shen, A., Zhou, Y., Shrum, C. K., Han, Y., Liu, J. O., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39199 · Cited by 258
Self-citationWang, F.-X., Xu, Y., Sullivan, J., Souder, E., Argyris, E. G., Acheampong, E. A., Fisher, J., Sierra, M., Thomson, M. M., Najera, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522574 · Cited by 252
Interleukin-7 promotes HIV persistence during antiretroviral therapy
Vandergeeten, C., Fromentin, R., DaFonseca, S., Lawani, M. B., Sereti, I., Lederman, M. M., Ramgopal, M., Routy, J.-P., Sékaly, R.-P., & Chomont, N. (2013) · Blood · doi:10.1182/blood-2012-11-465625 · Cited by 249
Tyagi, M., Pearson, R. J., & Karn, J. (2010) · Journal of Virology · doi:10.1128/jvi.01519-09 · Cited by 249
Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
Lenasi, T., Contreras, X., & Peterlin, B. M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.016 · Cited by 245
Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006093 · Cited by 240
Prins, J. M., Jurriaans, S., van Praag, R. M. E., Blaak, H., van Rij, R., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S.-L., Fox, C. H., Roos, M. T. L., et al. (1999) · AIDS · doi:10.1097/00002030-199912030-00012 · Cited by 237
Cameron, P. U., Saleh, S., Sallmann, G., Solomon, A., Wightman, F., Evans, V. A., Boucher, G., Haddad, E. K., Sekaly, R.-P., Harman, A. N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002894107 · Cited by 230
Self-citationMehla, R., Bivalkar-Mehla, S., Zhang, R., Handy, I., Albrecht, H., Giri, S., Nagarkatti, P., Nagarkatti, M., & Chauhan, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011160 · Cited by 227
Saleh, S., Solomon, A., Wightman, F., Xhilaga, M., Cameron, P. U., & Lewin, S. R. (2007) · Blood · doi:10.1182/blood-2007-06-097907 · Cited by 227
Self-citationGustafson, K. R., Cardellina, J. H., McMahon, J. B., Gulakowski, R. J., Ishitoya, J., Szallasi, Z., Lewin, N. E., Blumberg, P. M., & Weislow, O. S. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a006 · Cited by 218
Han, Y., Lin, Y. B., An, W., Xu, J., Yang, H.-C., O'Connell, K., Dordai, D., Boeke, J. D., Siliciano, J. D., & Siliciano, R. F. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.008 · Cited by 215
Self-citationHMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription
Contreras, X., Barboric, M., Lenasi, T., & Peterlin, B. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030146 · Cited by 206
Keedy, K. S., Archin, N. M., Gates, A. T., Espeseth, A., Hazuda, D. J., & Margolis, D. M. (2009) · Journal of Virology · doi:10.1128/jvi.02585-08 · Cited by 200
Self-citationSpina, C. A., Guatelli, J. C., & Richman, D. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2977-2988.1995 · Cited by 194
Self-citationRasmussen, T. A., Søgaard, O. S., Brinkmann, C., Wightman, F., Lewin, S. R., Melchjorsen, J., Dinarello, C., Østergaard, L., & Tolstrup, M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23800 · Cited by 193
Self-citationArchin, N. M., Eron, J. J., Palmer, S., Hartmann-Duff, A., Martinson, J. A., Wiegand, A., Bandarenko, N., Schmitz, J. L., Bosch, R. J., Landay, A. L., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6df4 · Cited by 186
Self-citationBosque, A., Famiglietti, M., Weyrich, A. S., Goulston, C., & Planelles, V. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002288 · Cited by 185
Self-citationSpina, C. A., Prince, H. E., & Richman, D. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119342 · Cited by 185
Self-citationScripture-Adams, D. D., Brooks, D. G., Korin, Y. D., & Zack, J. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13077-13082.2002 · Cited by 183
Swiggard, W. J., Baytop, C., Yu, J. J., Dai, J., Li, C., Schretzenmair, R., Theodosopoulos, T., & O'Doherty, U. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14179-14188.2005 · Cited by 182
Blankson, J. N., Finzi, D., Pierson, T. C., Sabundayo, B. P., Chadwick, K. R., Margolick, J. B., Quinn, T. C., & Siliciano, R. F. (2000) · The Journal of Infectious Diseases · doi:10.1086/317615 · Cited by 178
Self-citationCD28 ligation in T-cell activation: evidence for two signal transduction pathways.
Ledbetter, J., Imboden, J., Schieven, G., Grosmaire, L., Rabinovitch, P., Lindsten, T., Thompson, C., & June, C. (1990) · Blood · doi:10.1182/blood.v75.7.1531.1531 · Cited by 170
Chen, R., Liu, M., Li, H., Xue, Y., Ramey, W. N., He, N., Ai, N., Luo, H., Zhu, Y., Zhou, N., et al. (2008) · Genes & Development · doi:10.1101/gad.1636008 · Cited by 163
Archin, N. M., Keedy, K. S., Espeseth, A., Dang, H., Hazuda, D. J., & Margolis, D. M. (2009) · AIDS · doi:10.1097/qad.0b013e32832ec1dc · Cited by 162
Self-citationDynamics of Total, Linear Nonintegrated, and Integrated HIV‐1 DNA In Vivo and In Vitro
Koelsch, K. K., Liu, L., Haubrich, R., May, S., Havlir, D., Günthard, H. F., Ignacio, C. C., Campos‐Soto, P., Little, S. J., Shafer, R., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/525283 · Cited by 162
Self-citationDeChristopher, B. A., Loy, B. A., Marsden, M. D., Schrier, A. J., Zack, J. A., & Wender, P. A. (2012) · Nature Chemistry · doi:10.1038/nchem.1395 · Cited by 161
Bouchat, S., Gatot, J., Kabeya, K., Cardona, C., Colin, L., Herbein, G., Wit, S. D., Clumeck, N., Lambotte, O., Rouzioux, C., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835535f5 · Cited by 155
Pace, M. J., Graf, E. H., Agosto, L. M., Mexas, A. M., Male, F., Brady, T., Bushman, F. D., & O'Doherty, U. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002818 · Cited by 144
van Praag, R. M. E., Prins, J. M., Roos, M. T. L., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S. L., Schuitemaker, H., Eerenberg, A. J. M., Jurriaans, S., de Wolf, F., et al. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1011091300321 · Cited by 140
A Flexible Model of HIV-1 Latency Permitting Evaluation of Many Primary CD4 T-Cell Reservoirs
Lassen, K. G., Hebbeler, A. M., Bhattacharyya, D., Lobritz, M. A., & Greene, W. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030176 · Cited by 136
Self-citationHIV reservoirs and latency models
Pace, M. J., Agosto, L. M., Graf, E. H., & O’Doherty, U. (2011) · Virology · doi:10.1016/j.virol.2010.12.041 · Cited by 132
Budhiraja, S., Famiglietti, M., Bosque, A., Planelles, V., & Rice, A. P. (2012) · Journal of Virology · doi:10.1128/jvi.02413-12 · Cited by 131
Self-citationHIV latency and integration site placement in five cell-based models
Sherrill-Mix, S. A., Lewinski, M. K., Famiglietti, M., Bosque, A., Malani, N., Ocwieja, K. E., Berry, C. C., Looney, D. J., Shan, L., Agosto, L. M., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-90 · Cited by 127
Self-citationBryostatins: biological context and biotechnological prospects
Silva, A. E. T., Lim‐Fong, G., Sharp, K. H., & Haygood, M. G. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.09.018 · Cited by 126
Influence of Host Gene Transcription Level and Orientation on HIV-1 Latency in a Primary-Cell Model
Shan, L., Yang, H., Rabi, S. A., Bravo, H. C., Shroff, N. S., Irizarry, R. A., Zhang, H., Margolick, J. B., Siliciano, J. D., & Siliciano, R. F. (2011) · Journal of Virology · doi:10.1128/jvi.02536-10 · Cited by 123
Self-citationBryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
Pérez, M., de Vinuesa, A. G., Sánchez‐Duffhues, G., Márquez, N., Bellido, M., Muñoz‐Fernández, M. Á., Moreno, S., Castor, T. P., Calzado, M. A., & Muñóz, E. (2010) · Current HIV Research · doi:10.2174/157016210793499312 · Cited by 116
Determinants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
Duverger, A. E., Jones, J., May, J. E., Bibollet‐Ruche, F., Wagner, F. A., Cron, R. Q., & Kutsch, O. (2009) · Journal of Virology · doi:10.1128/jvi.02058-08 · Cited by 115
Gulakowski, R. J., McMahon, J. B., Buckheit, R. W., Gustafson, K. R., & Boyd, M. R. (1997) · Antiviral Research · doi:10.1016/s0166-3542(96)01004-2 · Cited by 106
An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency
Marini, A., Harper, J. M., & Romerio, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7713 · Cited by 103
Blažková, J., Chun, T., Belay, B. W., Murray, D., Justement, J. S., Funk, E. K., Nelson, A. K., Hallahan, C. W., Moir, S. L., Wender, P. A., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis412 · Cited by 99
Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells
Bosque, A., & Planelles, V. (2010) · Methods · doi:10.1016/j.ymeth.2010.10.002 · Cited by 96
Self-citationSaleh, S. M., Wightman, F., Ramanayake, S., Alexander, M. R., Kumar, N., Khoury, G., Pereira, C. F., Purcell, D. F. J., Cameron, P. U., & Lewin, S. R. (2011) · Retrovirology · doi:10.1186/1742-4690-8-80 · Cited by 94
Self-citationHIV latency: experimental systems and molecular models
Hakre, S., Chávez, L., Shirakawa, K., & Verdin, E. M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00335.x · Cited by 86
Self-citationBartholomeeusen, K., Fujinaga, K., Xiang, Y., & Peterlin, B. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.464834 · Cited by 85
Edelstein, L. C., Micheva-Viteva, S., Phelan, B. D., & Dougherty, J. P. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0294 · Cited by 74
Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4+T Cells
Choudhary, S. K., Archin, N. M., & Margolis, D. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/529525 · Cited by 73
Self-citationNF-κ B-Dependent and -Independent Pathways of HIV Activation in a Chronically Infected T Cell Line
Antoni, B. A., Rabson, A. B., Kinter, A. L., et al. (1994) · Virology · doi:10.1006/viro.1994.1390 · Cited by 67
Calcium/Calcineurin Synergizes with Prostratin to Promote NF-κB Dependent Activation of Latent HIV
Chan, J. K., Bhattacharyya, D., Lassen, K. G., Ruelas, D. S., & Greene, W. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077749 · Cited by 66
Self-citationDown-Regulation of IL-7Rα Expression in Human T Cells via DNA Methylation
Kim, H., Hwang, K., Kim, K.-C., & Kang, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5473 · Cited by 64
Siegel, D. S. D., Zhang, X., Feinman, R., Teitz, T., Zelenetz, A. D., Richon, V. M., Rifkind, R. A., Marks, P. A., & Michaeli, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.162 · Cited by 59
Lewin, S. R., Murray, J. M., Solomon, A. E., Wightman, F., Cameron, P. U., Purcell, D., Zaunders, J., Grey, P., Bloch, M. T., Smith, D. E., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815dbf7f · Cited by 46
Self-citationMicheva‐Viteva, S., Kobayashi, Y., Edelstein, L. C., Pacchia, A. L., Lee, H.-L. R., Graci, J. D., Breslin, J. J., Phelan, B. D., Miller, L. K., Colacino, J. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195537 · Cited by 44
Tat-independent replication of human immunodeficiency viruses.
Luznik, L., Kraus, G., Guatelli, J. C., Richman, D. D., & Wong‐Staal, F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117660 · Cited by 38
Vlach, J., & Pitha, P. M. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-11-2401 · Cited by 32
Interleukin-7 Induces HIV Type 1 Outgrowth From Peripheral Resting CD4+ T Cells
Lehrman, G. K., Ylisastigui, L., Bosch, R. J., & Margolis, D. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00015 · Cited by 31
Self-citationIrie, K., Yanagita, R. C., & Nakagawa, Y. (2010) · Medicinal Research Reviews · doi:10.1002/med.20220 · Cited by 31
Reuse, S., Colin, L., Calao, M., Kabeya, K., Gatot, J., Bouchat, S., Guiguen, A., Vanhulle, C., Cardona, C., Lamine, A., et al. (2010) · Cited by 29
A genetic and molecular toolbox for analyzing histone ubiquitylation and sumoylation in yeast
Trujillo, K. M., Tyler, R. K., Ye, C., Berger, S. L., & Osley, M. A. (2011) · Methods · doi:10.1016/j.ymeth.2011.02.003 · Cited by 15
Cited by
Elliott, J. H., Wightman, F., Solomon, A., Ghneim, K., Ahlers, J., Cameron, M. J., Smith, M. Z., Spelman, T., McMahon, J., Velayudham, P., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004473 · Cited by 504
Self-citationInternational AIDS Society global scientific strategy: towards an HIV cure 2016
International AIDS Society Towards a Cure Working Group, Deeks, S. G., Lewin, S. R., Ross, A. L., Ananworanich, J., Benkirane, M., Cannon, P., Chomont, N., Douek, D., Lifson, J. D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4108 · Cited by 425
Self-citationEx vivo analysis identifies effective HIV-1 latency–reversing drug combinations
Laird, G. M., Bullen, C. K., Rosenbloom, D. I. S., Martin, A. R., Hill, A. L., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80142 · Cited by 391
Self-citationHIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
Ganor, Y., Real, F., Sennepin, A., Dutertre, C.-A., Prevedel, L., Xu, L., Tudor, D., Charmeteau, B., Couedel-Courteille, A., Marion, S., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0335-z · Cited by 303
Darcis, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005063 · Cited by 281
Metadata
- Authors
- Spina, C. A., Anderson, J., Archin, N. M., Bosque, A., Chan, J., Famiglietti, M., Greene, W. C., Kashuba, A., Lewin, S. R., Margolis, D. M., Mau, M., Ruelas, D., Saleh, S., Shirakawa, K., Siliciano, R. F., Singhania, A., Soto, P. C., Terry, V. H., Verdin, E., Woelk, C., Wooden, S., Xing, S., & Planelles, V.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-12-26
- Volume
- 9
- Issue
- 12
- Pages
- e1003834
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2100859269
- Cited by
- 403
- References
- 86
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.